awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q52844170-61B50DEA-618D-43F7-A0C0-12A57039D79C
Q52844170-61B50DEA-618D-43F7-A0C0-12A57039D79C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52844170-61B50DEA-618D-43F7-A0C0-12A57039D79C
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.
P2860
Q52844170-61B50DEA-618D-43F7-A0C0-12A57039D79C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52844170-61B50DEA-618D-43F7-A0C0-12A57039D79C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b8c63e41f609977f2ec7a5d68ddb0ea30b44e9d8
P2860
Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.